These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34611278)

  • 1. A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer.
    Kure S; Satoi S; Kitayama T; Nagase Y; Nakano N; Yamada M; Uchiyama N; Miyashita S; Iida S; Takei H; Miyashita M
    Sci Rep; 2021 Oct; 11(1):19801. PubMed ID: 34611278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of breast cancer risk with volatile biomarkers in breath.
    Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S
    Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Volatile Organic Compounds (VOCs) in Urine via Gas Chromatography-Mass Spectrometry QTOF to Differentiate Between Localized and Metastatic Models of Breast Cancer.
    Woollam M; Teli M; Angarita-Rivera P; Liu S; Siegel AP; Yokota H; Agarwal M
    Sci Rep; 2019 Feb; 9(1):2526. PubMed ID: 30792417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.
    Bannaga AS; Tyagi H; Daulton E; Covington JA; Arasaradnam RP
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
    Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
    Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
    Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
    PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of breast cancer using volatile biomarkers in the breath.
    Phillips M; Cataneo RN; Ditkoff BA; Fisher P; Greenberg J; Gunawardena R; Kwon CS; Tietje O; Wong C
    Breast Cancer Res Treat; 2006 Sep; 99(1):19-21. PubMed ID: 16502014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer.
    Gao Q; Su X; Annabi MH; Schreiter BR; Prince T; Ackerman A; Morgas S; Mata V; Williams H; Lee WY
    Clin Genitourin Cancer; 2019 Jun; 17(3):183-190. PubMed ID: 30853355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of lung cancer using volatile biomarkers in breath.
    Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Greenberg J; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P
    Cancer Biomark; 2007; 3(2):95-109. PubMed ID: 17522431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
    Chen X; Chen H; Dai M; Ai J; Li Y; Mahon B; Dai S; Deng Y
    Oncotarget; 2016 Jun; 7(24):36622-36631. PubMed ID: 27153558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
    Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
    Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
    Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
    BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.
    Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H
    Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
    Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
    Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.
    Hadi NI; Jamal Q; Iqbal A; Shaikh F; Somroo S; Musharraf SG
    Sci Rep; 2017 May; 7(1):1715. PubMed ID: 28496143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.